Digital health company Oto is partnering with clinical trial startup Lindus Health to conduct a fully remote digital trial aimed at improving access to tinnitus therapy for patients.
The trial will involve 198 adult patients in the UK using Oto's smartphone tinnitus management program and comparing its effectiveness to therapist-delivered cognitive behavioural therapy (CBT) in reducing self-reported tinnitus severity.
If Oto's digital solution proves as effective as traditional therapy, it could offer a cost-effective treatment option for tinnitus sufferers. Lindus Health, known for its fast clinical trial capabilities, will manage the trial from protocol development to data collection, recruitment, and monitoring using its CitrusClinical platform.
This approach aims to expedite the availability of innovative tinnitus treatments for patients across the UK. Tinnitus affects approximately 15% of the UK population, and this trial aims to help individuals better manage their symptoms through remote coaching.
Click here to read the original news story.